← Back to catalogue

Sphincterotome AG-50910-0525-W2545

EUDAMEDFDA 510(k)

Class IIb (EU MDR)

Ref AG-50910-0525-W2545510(k) K201121

by Hangzhou AGS MedTech Co., Ltd.

Identity

Device Name
Sphincterotome EUDAMED
Model / Reference
AG-50910-0525-W2545 EUDAMED

Identifiers

Primary DI / UDI-DI
06959664934067 EUDAMED
Basic UDI-DI
695966495091000016F EUDAMED
EMDN Code
G03040202 PAPILLOTOMES / SPHINCTEROTOMES, TRIPLE (OR MORE) LUMEN EUDAMED

Classification

Device Class
Class IIb EUDAMED
Market of Registration
France EUDAMED

Clinical & Handling

Sterile

Yes

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

The Sphincterotome is an electrosurgical endoscopic device designed for transendoscopic sphincterotomy of the Papilla of Vater and/or the Sphincter of Oddi, as classified under nomenclature code G03040202. It facilitates cannulation of the biliary ducts through controlled incision of the sphincter tissue, enabling access for diagnostic or therapeutic procedures.

Supplied sterile and intended for single-use, the Sphincterotome AG-50910-0525-W2545 is packaged in sterile containers (UDI DI: 06959664934067, 16959664934064, 26959664934061). It is non-reusable, non-implantable, and non-latex, with no animal or human tissue components. Authorised under FDA 510(k) clearance (K201121) and MDR, it adheres to Class IIb regulatory standards and carries a UDI (695966495091000016F) for traceability.

Frequently asked questions

What is the Sphincterotome AG-50910-0525-W2545 used for?

The Sphincterotome AG-50910-0525-W2545 is an electrosurgical endoscopic device designed specifically for transendoscopic sphincterotomy of the Papilla of Vater and/or the Sphincter of Oddi. This procedure creates a controlled incision in the sphincter tissue to facilitate cannulation of the biliary ducts, enabling access for diagnostic or therapeutic interventions such as ERCP (Endoscopic Retrograde Cholangiopancreatography).

How is the Sphincterotome AG-50910-0525-W2545 supplied and what are its sterility and reuse details?

The Sphincterotome AG-50910-0525-W2545 is supplied sterile in sealed containers, ensuring readiness for immediate use without additional preparation. It is intended for single-use only and must not be reused, as reuse could compromise sterility and device integrity. The packaging includes unique UDI-DI codes (06959664934067, 16959664934064, 26959664934061) for traceability.

Does the Sphincterotome AG-50910-0525-W2545 contain latex or animal/human tissues?

No, the Sphincterotome AG-50910-0525-W2545 is non-latex and contains no animal or human tissue components. This design reduces the risk of allergic reactions or contamination concerns, making it suitable for patients with latex sensitivities or other restrictions.

What regulatory approvals does the Sphincterotome AG-50910-0525-W2545 hold?

The device holds FDA 510(k) clearance (K201121) and is compliant with the EU Medical Device Regulation (MDR). It is classified under Class IIb and adheres to strict regulatory standards for endoscopic electrosurgical instruments. The UDI (695966495091000016F) ensures traceability throughout its lifecycle.

How should the Sphincterotome AG-50910-0525-W2545 be stored before use?

The Sphincterotome should be stored in its original sterile packaging in a clean, dry environment protected from direct sunlight, extreme temperatures, and physical damage. Avoid exposure to moisture or contaminants, as this could compromise sterility. Once opened, the device must be used immediately and discarded per single-use guidelines.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Hangzhou AGS MedTech Co., Ltd. - bioags.com, K222421 - Sphincterotome | FDA 510 (k), Sphincterotome (K201121) - FDA 510 (k)

Authorization Coverage (2 countries)

Regulatory Authorizations

United States Active

FDA_510K

United States Active

FDA_510K

European Union Active

CE/MDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000011718
Authorised Representative
Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001

Sources (2)

  • EUDAMED 4549a797-44e5-432b-a1d0-adf4bd9799f0 85 fields · synced Oct 5, 2026
  • FDA 510(k) K201121 1 fields · synced May 18, 2026